BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20180101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191015
DTEND;VALUE=DATE:20191017
DTSTAMP:20260515T022919
CREATED:20190509T101547Z
LAST-MODIFIED:20190509T110535Z
UID:20621-1571097600-1571270399@www.pharmajournalist.com
SUMMARY:SMi’s 9th Annual Orphan Drugs & Rare Diseases Conference
DESCRIPTION:SMi Group are proud to announce the 9th Annual Orphan Drugs and Rare Diseases Conference\, taking place on the 15th and 16th October 2019 in London\, UK. \n \nThe orphan drug market is continuously growing and is expected to reach $176 billion by 2020\, with a CGR of 10.5% just for orphan drugs – this is twice the growth rate of the overall prescription drug market (5.3% CGR from 2014-2020). By 2020\, orphan drugs are set to account for 19% of global prescription sales. \nThis is due to the arising interest for pharmaceutical companies\, primarily for the underlying benefits\, including the potential discovery of mechanisms for more common diseases\, and the involvement of many smaller biotechnology start-up companies who are more focused on rare diseases. \nThe 2019 agenda features various key presentations by leading solution providers\, biotechnology companies\, clinical researchers\, regulatory professionals and charity leaders discussing possible ways to accelerative orphan drug development and access to rare disease patients\, including the introduction of recent technologies and products to help aid the access of orphan drugs. \nBENEFITS OF ATTENDING \n\nHEAR about the success of orphan drug launches following the heavy involvement of patient advocacy programs\nDISCUSS the potential changes in assessing the development of medicines across Europe\nEXPLORE the future landscape orphan drugs following the market access and reimbursement challenges providers are currently facing.\n\nPLUS AN INTERACTIVE HALF-DAY POST-CONFERENCE WORKSHOP\nThursday 17th October 2019\nA deep dive into strategies for accelerating patient access of orphan drugs\nWorkshop Leader: Workshop Leaders: Solange Corriol-Rohou\, Senior Director Regulatory Affairs & Policy Europe\, AstraZeneca\nCecile Ollivier\, Chief Operating Officer\, Aparito \nWHO SHOULD ATTEND? \nCEOs\, CSOs\, Vice Presidents\, Directors\, Heads\, Principals working in: \n\nMedical Affairs\nMedical Advisory\nClinical Operations\nRare Disease Research\nPatient Advocacy\nCommercial Officer\nOrphan Drug Therapeutics\nHealthcare\nRegulatory Affairs\nRare Disease Charity Officers\n\nFor more details and to register or this event\, visit the website at http://www.orphandrugs.co.uk/PJWL \nEARLY BIRD-RATES  \n\nBOOK BY 31ST MAY AND SAVE £400\nBOOK BY 28TH JUNE AND SAVE £300\nBOOK BY 30TH AUGUST AND SAVE £200
URL:https://www.pharmajournalist.com/event/orphan-drugs-rare-diseases-conference/
LOCATION:Holiday Inn Kesington Forum\, London\, UK\, London\, United Kingdom
ORGANIZER;CN="SMi Group Ltd":MAILTO:ssapal@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191015
DTEND;VALUE=DATE:20191017
DTSTAMP:20260515T022919
CREATED:20190625T112416Z
LAST-MODIFIED:20190625T112709Z
UID:21320-1571097600-1571270399@www.pharmajournalist.com
SUMMARY:Marketing and Customer Innovation Europe
DESCRIPTION:We’re at a crossroads. On the one hand\, pharma marketeers must adopt and master an array of technological innovations to transform customer relationships and better meet rising expectations. \nOn the other\, successful innovation is currently inhibited by our failure to master the basics – with inconsistent multichannel interaction and a low cultural acceptance of non-traditional methods\, whether it’s digital or education-led initiatives. \nLet’s build the capability to create new collaborations and partnerships\, both internally and externally\, to strengthen what’s possible yet at the same time deliver on the fundamentals of customer-value. It’s no longer a nice-to-have – we must do this or face rapid extinction.  \neyeforpharma Marketing and Customer Innovation Europe will bring together 250+ Marketing\, Digital\, CX\, IT/CRM and Business Partnership/Technology pharma executives to bridge internal divides\, share the industry pushing case studies and build market-leading customer experiences. \nAttend and gain unique insights on: \n\n          Collaborate or die.\nBreak internal silos in commercial and medical affairs\, partner with healthcare’s key innovators and decision makers\, and bring the brightest FMCG knowledge and leadership inside\n          You’re brand obsessed!\nCreate true customer partnerships and influence behaviours with an above-brand\, education-led approach\n          Digital transformation needs a cultural revolution.\nDemonstrate the value of digital initiatives to ensure adoption across affiliates and departments\n          Harness big data.\nPersonalise customer interactions with an internal infrastructure built to comprehend and connect insights\n          Achieve customer-centricity.\nEnsure new channel innovations and digital investments remain purpose-led to meet customer needs\n          Real-life technological innovation.\nChannel your investments and cut through unnecessary hyperbole with current applications of technology breakthroughs\n\n4 Reasons to Attend: \nCase Studies: Practical\, tangible advice and actions from your peers which you can put into practise in your own company \nOut of Industry Speakers: Hear from some of the biggest leader in marketing out of the pharma industry sharing their top tips \nTeam Benefits: Group rates are now available for 2+ attendees\, to ensure all interested peers can take advantage of this learning opportunity \nAll Stakeholders in One Room: Working together to ensure we are engaging in solution focused exchanges across all departments \nBook before 19th July to save €300
URL:https://www.pharmajournalist.com/event/marketing-and-customer-innovation-europe/
LOCATION:Novotel West London One Shortlands\, London\, W6 8DR\, United Kingdom
ORGANIZER;CN="eyeforpharma":MAILTO:mmayhew@eyeforpharma.com
END:VEVENT
END:VCALENDAR